Drug application
OTOBIOTIC (HYDROCORTISONE, POLYMYXIN B SULFATE)
Drugs@FDA ANDA 062302 · SCHERING
Key facts
| Drug name | OTOBIOTIC |
|---|---|
| Active ingredients | HYDROCORTISONE, POLYMYXIN B SULFATE |
| Application type | ANDA |
| Application number | 062302 |
| Company | SCHERING |
| Dosage forms | SOLUTION/DROPS, OTIC |
| Strength | 5MG/ML;EQ 10,000 UNITS BASE/ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Dec 1, 1981 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.